Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| JPMorgan Chase | 2.72% | $3.59M | $823.62B | 9.38% | 72 Outperform | |
| Enterprise Products Partners | 2.66% | $3.51M | $80.50B | 11.27% | 73 Outperform | |
| ASML Holding | 2.55% | $3.36M | $539.78B | 87.16% | 81 Outperform | |
| Exxon Mobil | 2.48% | $3.28M | $626.04B | 37.15% | 74 Outperform | |
| Novartis | 2.47% | $3.25M | $309.51B | 54.70% | 80 Outperform | |
| Morgan Stanley | 2.43% | $3.20M | $272.01B | 23.17% | 76 Outperform | |
| Nexstar Media Group | 2.37% | $3.12M | $7.01B | 50.76% | 69 Neutral | |
| Merck & Company | 2.37% | $3.12M | $301.34B | 46.26% | 80 Outperform | |
| KLA | 2.35% | $3.10M | $191.91B | 95.02% | 77 Outperform | |
| Broadcom | 2.30% | $3.03M | $1.54T | 39.53% | 76 Outperform |